Donald Trump's tariff move impacts Indian pharma stocks. Companies like Sun Phar...
Stock market recommendations: Mirae Asset Sharekhan's Somil Mehta recommends buy...
Pharmaceutical stocks, particularly Indian firms, plummeted following President ...
India Ratings and Research (Ind-Ra) anticipates minimal credit profile impact on...
US President Donald Trump has said his administration will impose 100 per cent i...
US President Trump announced a 100% tariff on imported branded and patented phar...
Indian firm Natco Pharma is set to acquire substantial stakes in South African p...
Asian drug stocks faced a downturn. This followed US President Trump's tariff th...
Dalal Street plunged this week, with over 440 BSE 500 stocks in red, following U...
India's top-10 companies saw their combined market valuation shrink by nearly Rs...
Stock market recommendations: Nifty and Bank Nifty experienced significant decli...
An alert was issued against specific batches of Coldrif from Sresan Pharmaceutic...
India Inc. saw revenue grow by up to 6% in the July-September quarter, driven by...
India and China are set to discuss a trade package focusing on essential commodi...
Fitch Ratings cautions that while Indian corporates have limited direct exposure...
US President Trump's proposed tariffs on pharmaceutical imports, potentially rea...
